SCHEMBL5634573

SCHEMBL5634573

COC(=O)c1cccc(C(=O)C2CN(CC(=O)N(C)C)CC(C(=O)c3cccc(C(=O)O)c3C)C2c2cccc(F)c2C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 2/20 0.34
AAK1 Q2M2I8 1/20 0.33
TYK2 P29597 1/20 0.32
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
RBP4 P02753 1/20 0.32
HTR7 P34969 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
IL2 P60568 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CHEK1 O14757 1/20 0.31
PRKAB2 O43741 1/20 0.31
NUAK1 O60285 1/20 0.31
MAPK1 P28482 1/20 0.31
PRKAG1 P54619 1/20 0.31
PRKAA2 P54646 1/20 0.31
PRKAA1 Q13131 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024037 0.93 ALDH1A1 (0.37) ALDH1A1KMT2AMEN1AAK1CYP11B1
SCHEMBL4024035 0.93 ALDH1A1 (0.37) ALDH1A1KMT2AMEN1AAK1CYP11B1
SCHEMBL5635105 0.90 EED (0.31) ALDH1A1
SCHEMBL4022581 0.88 ALDH1A1 (0.35) ALDH1A1KMT2AMEN1AAK1TYK2
SCHEMBL4022580 0.88 ALDH1A1 (0.35) ALDH1A1KMT2AMEN1AAK1TYK2
SCHEMBL4019982 0.82 KMT2A (0.39) ALDH1A1KMT2AMEN1MAPK1NPC1
SCHEMBL4019987 0.82 KMT2A (0.39) ALDH1A1KMT2AMEN1MAPK1NPC1
SCHEMBL4022370 0.82 KDM4E (0.37) ALDH1A1
SCHEMBL4022374 0.82 KDM4E (0.37) ALDH1A1
SCHEMBL4027956 0.82 KDM2B (0.43) ALDH1A1KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161674-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2007-07-12 US claimed
US-20070161674-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161674-A1 Certain chemical entities, compositions, and methods TP53, VHL, RB1 ALDH1A1 258/4885KMT2A 2820/4885MEN1 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.